Inpatient and Outpatient Orderable

Hepatitis C Virus (HCV) FibroSure (LabCorp)

Synonyms

HEPATITIS C VIRUS FIBROSURE
LAB11792

Cerner Name

Clinical Info

For the assessment of liver status following a diagnosis of HCV as well as post-treatment assessment of liver status six months after completion of antiviral therapy. For use in patients who are at risk of complications from a liver biopsy.

Specimen Sources

Blood, Arterial Blood, Capillary Blood, Central Line Blood, Venous

Specimen Types

Blood

Container

Gold Top Tube

Collection Instructions

Container/Tube: 2 Gold top tube- serum gel top
Specimen: 3.5 mL serum (2 mL min) - Separate serum from cells within two hours of collection.
Transport Temperature: Frozen
Stability: 72 Hours Room Temperature or Refrigerated
7 Days Frozen

Patient should be fasting for at least eight hours.

Note: Please submit Two aliquots: 2.5 ml frozen serum in one & 0.5 ml in other tube ( minimum volume: 1.5 mL Frozen serum + 0.5 mL Frozen serum)

Patient Preparation Patient should be fasting for at least eight hours

Causes for Rejection Gross hemolysis; gross lipemia; improper labeling; nonfasting specimen; patient less than 14 years of age

Specimen Volume

3.5 mL serum (2 mL min) - Separate serum from cells within two hours of collection.

Transport Instructions

Frozen

Specimen Stability

72 Hours Room Temperature or Refrigerated
7 Days Frozen

Patient should be fasting for at least eight hours.

Note: Please submit Two aliquots: 2.5 ml frozen serum in one & 0.5 ml in other tube ( minimum volume: 1.5 mL

Methodology

FibroSURE

Days Performed

Monday - Friday, 7 Day TAT

Performing Laboratory

LabCorp of America

CPT

81596

PDM

5907810

Only Orderable at Locations:

Orderable Everywhere

Results

Component Name	Base Name	Common Name	External Name
FIBROSIS SCORE	FIBROSISSCR	FIBROSIS SCORE	Fibrosis Score
FIBROSIS STAGE	FIBROSISSTG	FIBROSIS STAGE	Fibrosis Stage
NECROINFLAMMAT ACTIVITY SCORE	NECROINFLAM	NECROINFLAMMAT ACTIVITY SCORE	FibroSure Necroinflammat Activity Score
NECROINFLAMMAT ACTIVITY GRADE	NECROINFLAM	NECROINFLAMMAT ACTIVITY GRADE	FibroSure Necroinflammat Activity Grade
METHODOLOGY (LABCORP)	METHOD	METHODOLOGY LABCORP	Methodology
ALPHA 2-MACROGLOBULINS, QN	A2MACROGLQN	ALPHA 2 MACROGLOBULINS QN	Alpha 2-Macroglobulins, Qn
HAPTOGLOBIN, SERUM	HAPTOGLOBIN	HAPTOGLOBIN	Haptoglobin
APOLIPOPROTEIN A-1	APOA1	APOLIPOPROTEIN A 1	Apolipoprotein A-1
BILIRUBIN, TOTAL	BILITOT	BILIRUBIN TOTAL	Bilirubin, Total
GGT	GGT	GGT	GGT
ALT (SGPT) P5P	ALT	ALT SGPT P5P	ALT (SGPT) P5P
INTERPRETATIONS:	HCVINT	INTERPRETATIONS	FibroSure Interpretations
FIBROSIS SCORING:	FIBROSISSCR	FIBROSIS SCORING	Fibrosis Scoring
NECROINFLAMM ACTIVITY SCORING:	NECROINFLAM	NECROINFLAMM ACTIVITY SCORING	FibroSure Necroinflammat Activity Scoring
LIMITATIONS:	LIMITA	LIMITATIONS	FibroSure Limitations
COMMENT:	COMMENT	COMMENT	Comment
COMMENT 2:	COMMENT2	COMMENT 2	FibroSure Comment 2

Result Interpretation

Individual Serum Markers	Male	Female
Alanine aminotransferase (ALT)	0−55 IU/L	0−40 IU/L
α₂-Macroglobulin	110−276 mg/dL	110−276 mg/dL
Apolipoprotein A-1	110−180 mg/dL	110−205 mg/dL
Bilirubin, total	0.0−1.2 mg/dL	0.0−1.2 mg/dL
γ-Glutamyl transferase (GGT)	0−65 IU/L	0−60 IU/L
Haptoglobin	34−200 mg/dL	34−200 mg/dL

METAVIR Group Scoring System

Fibrosis Stage (FibroTest)	Range
F0−No fibrosis	0.00−0.21
F0−F1	0.21−0.27
F1−Portal fibrosis	0.27−0.31
F1−F2	0.31−0.48
F2−Bridging fibrosis with few septa	0.48−0.58
F3−Bridging fibrosis with many septa	0.58−0.72
F3−F4	0.72−0.74
F4−Cirrhosis	0.74−1.00

Activity Stage (ActiTest)	Range
A0−No activity	0.00−0.17
A0−A1	0.17−0.29
A1−Minimal activity	0.29−0.36
A1−A2	0.36−0.52
A2−Moderate activity	0.52−0.60
A2−A3	0.60−0.63
A3−Severe activity	0.63−1.00

Forms

LAB11792

Search: .supercomplete-item { width: 600px; white-space: nowrap; overflow: hidden; text-overflow: ellipsis; } $(document).ready(function() { $("#search_input").supercomplete(); });